Research progress of combination clinical application of foscarnet sodium
Author:
Affiliation:

Clc Number:

R978.7

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Foscarnet sodium is a broad-spectrum non-nucleoside antiviral drug which can effectively block the replication of various DNA viruses such as herpes virus, human papillomavirus, hepatitis B virus, human immunodeficiency virus and related infections. Foscarnet sodium is often used in combination with a variety of drugs in clinic to play a full role in antivirus. In this paper, the research on the combination use of foscarnet sodium in clinic, including the treatment of herpes, hepatitis B, human papillomavirus infection, and adverse reactions of combination therapy are reviewed.

    Reference
    Related
Get Citation

温海燕, 宋金春.膦甲酸钠临床联合用药的研究概况[J].中国感染控制杂志英文版,2019,18(1):89-92. DOI:10.12138/j. issn.1671-9638.20193734.
WEN Hai-yan, SONG Jin-chun. Research progress of combination clinical application of foscarnet sodium[J]. Chin J Infect Control, 2019,18(1):89-92. DOI:10.12138/j. issn.1671-9638.20193734.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:March 19,2018
  • Revised:
  • Adopted:
  • Online: January 28,2019
  • Published: